Document is current
Any future updates will be listed below
-
Authors
Ding, Chenbo
Yu, Zhibin
Sefik, Esen https://orcid.org/0000-0002-6807-3498
Zhou, Jing https://orcid.org/0000-0001-6601-4446
Kaffe, Eleanna
Wang, Gaoyang
Li, Bin https://orcid.org/0000-0002-7640-8884
Flavell, Richard A. https://orcid.org/0000-0003-4461-0778
Hu, Weiguo
Ye, Youqiong https://orcid.org/0000-0001-8332-4710
Li, Hua-Bing https://orcid.org/0000-0003-3573-6803
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82030042)
National Natural Science Foundation of China (32070917)
National Natural Science Foundation of China (82111540277)
National Natural Science Foundation of China (82341017)
- License Information
-
More Information
Article History
Received: 27 July 2022
Accepted: 28 April 2023
First Online: 5 June 2023
Competing interests
: R.A.F. is a consultant for GSK and Zai Lab; H.-B.L. is a consultant for CARsgen Therapeutics. The other authors declare no competing interests.
